Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms
A Mafficini, A Scarpa - Endocrine reviews, 2019 - academic.oup.com
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …
Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms
L de Mestier, J Cros, C Neuzillet, O Hentic, A Egal… - …, 2017 - karger.com
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are a heterogeneous
subgroup of rare neoplasms that represent about a third of all poorly differentiated …
subgroup of rare neoplasms that represent about a third of all poorly differentiated …
Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry
JR Conner, JL Hornick - Advances in anatomic pathology, 2015 - journals.lww.com
Carcinoma of unknown primary origin (CUP) is one of the 10 most prevalent malignancies.
CUP patients in whom a site of origin can be ascribed have better outcomes than those in …
CUP patients in whom a site of origin can be ascribed have better outcomes than those in …
Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review
EE Ilett, SW Langer, IH Olsen, B Federspiel, A Kjær… - Diagnostics, 2015 - mdpi.com
To date, empirical literature has generally been considered lacking in relation to
neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine …
neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine …
Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are classified based on
morphology and graded based on their proliferation rate as either well-differentiated low …
morphology and graded based on their proliferation rate as either well-differentiated low …
Cancer of unknown primary: challenges and progress in clinical management
N Laprovitera, M Riefolo, E Ambrosini, C Klec… - Cancers, 2021 - mdpi.com
Simple Summary Patients with cancer of unknown primary site suffer the burden of an
uncertain disease, which is characterized by the impossibility to identify the tissue where the …
uncertain disease, which is characterized by the impossibility to identify the tissue where the …
The problem of high-grade gastroenteropancreatic neuroendocrine neoplasms: well-differentiated neuroendocrine tumors, neuroendocrine carcinomas, and beyond
H Sorbye, E Baudin, A Perren - Endocrinology and Metabolism …, 2018 - endo.theclinics.com
Background The 2010 World Health Organization (WHO) classification of
gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) introduced morphology …
gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) introduced morphology …
Comparison of survival and patterns of recurrence in gastric neuroendocrine carcinoma, mixed adenoneuroendocrine carcinoma, and adenocarcinoma
Importance Gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma
are rare pathological types of gastric cancer, and there is a lack of multicenter studies …
are rare pathological types of gastric cancer, and there is a lack of multicenter studies …
A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases
S Kuji, R Watanabe, Y Sato, T Iwata, Y Hirashima… - Gynecologic …, 2017 - Elsevier
Objective High-grade neuroendocrine carcinoma of uterine cervix (HGNCUC) has been
recognized as a highly malignant tumor. Therapeutic strategy specific to neuroendocrine …
recognized as a highly malignant tumor. Therapeutic strategy specific to neuroendocrine …
Surgery in patients with gastro-entero-pancreatic neuroendocrine carcinomas, neuroendocrine tumors G3 and high grade mixed neuroendocrine-non-neuroendocrine …
P Holmager, SW Langer, A Kjaer, L Ringholm… - … Treatment Options in …, 2022 - Springer
Opinion statement In the 2019 WHO guidelines, the classification of gastro-entero-
pancreatic neuroendocrine neoplasms (GEP NEN) has changed from one being based on …
pancreatic neuroendocrine neoplasms (GEP NEN) has changed from one being based on …